NO20073395L - Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer - Google Patents

Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Info

Publication number
NO20073395L
NO20073395L NO20073395A NO20073395A NO20073395L NO 20073395 L NO20073395 L NO 20073395L NO 20073395 A NO20073395 A NO 20073395A NO 20073395 A NO20073395 A NO 20073395A NO 20073395 L NO20073395 L NO 20073395L
Authority
NO
Norway
Prior art keywords
gastric
coating composition
composition containing
resistant
sticking agent
Prior art date
Application number
NO20073395A
Other languages
English (en)
Norwegian (no)
Inventor
George Reyes
Thomas Farrell
Kurt Fegely
Ali Rajabi-Siahboomi
Budhi Simon
Cara Young
Original Assignee
Bpsi Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36588225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073395(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bpsi Holdings Inc filed Critical Bpsi Holdings Inc
Publication of NO20073395L publication Critical patent/NO20073395L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NO20073395A 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer NO20073395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63708304P 2004-12-17 2004-12-17
PCT/US2005/046326 WO2006066264A1 (en) 2004-12-17 2005-12-16 Enteric film coating composition containing enteric polymer micronized with detackifier

Publications (1)

Publication Number Publication Date
NO20073395L true NO20073395L (no) 2007-09-07

Family

ID=36588225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073395A NO20073395L (no) 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Country Status (15)

Country Link
US (1) US20060134216A1 (es)
EP (1) EP1827390A1 (es)
JP (1) JP2008524257A (es)
KR (1) KR20070094627A (es)
CN (1) CN101080217B (es)
AR (1) AR051722A1 (es)
AU (1) AU2005316235A1 (es)
BR (1) BRPI0518575A2 (es)
CA (1) CA2586425A1 (es)
IL (1) IL183579A0 (es)
MX (1) MX2007007221A (es)
NO (1) NO20073395L (es)
TW (1) TW200626185A (es)
WO (1) WO2006066264A1 (es)
ZA (1) ZA200704311B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2051704B1 (de) * 2006-08-18 2012-04-18 Evonik Röhm GmbH Pharmazeutische Zusammensetzung mit kontrollierter Wirkstoffabgabe für Wirkstoffe mit guter Löslichkeit in Wasser
AU2010248060A1 (en) 2009-05-12 2011-10-27 Bpsi Holdings, Llc. Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
CN102421421A (zh) * 2009-05-12 2012-04-18 Bpsi控股有限责任公司 含有抗黏性剂细微颗粒的包衣和覆有该包衣的基体
KR20130060220A (ko) * 2010-04-30 2013-06-07 다케다 야쿠힌 고교 가부시키가이샤 장용성 정제
MY162392A (en) * 2010-04-30 2017-06-15 Takeda Pharmaceuticals Co Enteric tablet
WO2014159814A1 (en) * 2013-03-13 2014-10-02 Patricia Oliver Formulations and tablets for treatment or prevention of neurological disorders
DK3307239T3 (da) 2015-06-12 2020-11-23 Vaxart Inc Formuleringer til indgivelse af RSV- og norovirusantigener i tyndtarmen
BR112020020783A2 (pt) * 2018-04-12 2021-01-26 Bpsi Holdings, Llc revestimentos acidificante e substratos resistentes à desintegração revestidos com os mesmos
US11458104B1 (en) 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN116617174B (zh) * 2023-05-12 2024-03-08 石家庄四药有限公司 一种含硫酸氢氯吡格雷和阿司匹林的片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656457A (en) * 1900-05-11 1900-08-21 Isaac Hirsch Knife.
US2595076A (en) * 1949-09-19 1952-04-29 Hudson Bay Mining & Smelting Selective flotation of zinc
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
CN1162917A (zh) * 1994-10-07 1997-10-22 伯温德药品服务公司 肠内涂层组合物,用其涂覆的方法和涂覆制品
ES2220989T3 (es) * 1995-09-21 2004-12-16 Pharma Pass Ii Llc Nueva composicion que contiene benzimidazol labil al acido y procedimiento para su preparacion.
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
IL150850A0 (en) * 2000-02-10 2003-02-12 Bpsi Holdings Inc Enteric coating compositions containing acrylic resin
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US6703004B2 (en) * 2002-04-03 2004-03-09 Revlon Consumer Products Corporation Method and compositions for bleaching hair
US20040255399A1 (en) * 2003-06-23 2004-12-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method and compositions for coloring hair with taurate copolymers

Also Published As

Publication number Publication date
KR20070094627A (ko) 2007-09-20
MX2007007221A (es) 2007-08-14
CA2586425A1 (en) 2006-06-22
CN101080217A (zh) 2007-11-28
CN101080217B (zh) 2012-07-18
WO2006066264A1 (en) 2006-06-22
AR051722A1 (es) 2007-01-31
US20060134216A1 (en) 2006-06-22
EP1827390A1 (en) 2007-09-05
AU2005316235A1 (en) 2006-06-22
BRPI0518575A2 (pt) 2009-04-28
JP2008524257A (ja) 2008-07-10
ZA200704311B (en) 2008-06-25
TW200626185A (en) 2006-08-01
IL183579A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
NO20073395L (no) Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer
MXPA05008491A (es) Sistemas de recubrimiento de pelicula nacarada y substratos recubiertos con la misma.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2008002573A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
MA31433B1 (fr) Inhibiteurs de la p70 s6 kinase
MY144209A (en) Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
MA34104B1 (fr) Revêtements améliorés à faible teneur en dioxyde de titane
EP2260835A3 (en) Composition for proteasome inhibition
RS51607B (sr) Novi lekovi za tretiranje hroničnog opstruktivnog oboljenja pluća
MX2008013040A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1.
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
MX2009002229A (es) Benzotriazoles como moduladores de cinasas.
WO2009021750A3 (en) Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
UA90742C2 (en) Pyrazolone derivatives
HK1074592A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
NO20072915L (no) Farmasoytisk preparat som inneholder belagte magnetiske partikler og fremgangsmate for fremstilling av disse, og diagnoseterapisystem
UA95715C2 (ru) Фосфадиазиновые производные, фармацевтическая композиция и их применение
NO20076515L (no) Hydantoinforbindelser
MX2010005516A (es) Composiciones que comprenden al menos un derivado del acido naftoico, de peroxido de benzoilo y al menos un agente filmogeno.
WO2006125181A3 (en) Piperidine derivatives and their use as stearoyl-coa desaturase modulators
MX2009003169A (es) Derivados de sulfonamida.
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application